학술논문

Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights.
Document Type
article
Source
Nature genetics. 50(4)
Subject
Schizophrenia Working Group of the Psychiatric Genomics Consortium
Brain
Chromatin
Animals
Zebrafish
Humans
Genetic Predisposition to Disease
Mitogen-Activated Protein Kinase 3
Microtubule-Associated Proteins
Zebrafish Proteins
Gene Expression Profiling
Schizophrenia
Gene Dosage
Multifactorial Inheritance
Quantitative Trait Loci
Protein Phosphatase 2
Genome-Wide Association Study
Human Genome
Genetics
Mental Health
Neurosciences
Brain Disorders
Serious Mental Illness
2.1 Biological and endogenous factors
Mental health
Developmental Biology
Biological Sciences
Medical and Health Sciences
Language
Abstract
Genome-wide association studies (GWAS) have identified over 100 risk loci for schizophrenia, but the causal mechanisms remain largely unknown. We performed a transcriptome-wide association study (TWAS) integrating a schizophrenia GWAS of 79,845 individuals from the Psychiatric Genomics Consortium with expression data from brain, blood, and adipose tissues across 3,693 primarily control individuals. We identified 157 TWAS-significant genes, of which 35 did not overlap a known GWAS locus. Of these 157 genes, 42 were associated with specific chromatin features measured in independent samples, thus highlighting potential regulatory targets for follow-up. Suppression of one identified susceptibility gene, mapk3, in zebrafish showed a significant effect on neurodevelopmental phenotypes. Expression and splicing from the brain captured most of the TWAS effect across all genes. This large-scale connection of associations to target genes, tissues, and regulatory features is an essential step in moving toward a mechanistic understanding of GWAS.